Effects of consumption of oat milk, soya milk, or cow's milk on plasma lipids and antioxidative capacity in healthy subjects

Annals of Nutrition and Metabolism

Volumn 42, Issue 4, 1998, Pages 211-220

  Onning G ^a   Akesson B ^a   Oste R ^a   Lundquist, I ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Antioxidant status; Cow's milk; Oat milk; Plasma lipids; Sensory evaluation; Soya milk

Indexed keywords

ANTIOXIDANT; BETA GLUCAN; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MILK; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIOXIDANTS; AVENA SATIVA; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPIDS; MALE; MILK; SOYBEANS;

AVENA; GLYCINE MAX;

EID: 0031659413     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012736     Document Type: Article

References (28)

1. Mensink RP, Katan MB: Effect of dietary fatty acids on serum lipids and lipoproteins: A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12:911-919.
2. WHO Expert Committee: Prevention of Coronary Heart Disease. Technical Report Series. Geneva, World Health Organisation, 1982.
3. Anderson JW, Bridges S-R: Hypocholesterolemic effects of oat bran in humans; in Wood PJ (ed): Oat Bran. St. Paul, American Association of Cereal Chemists, 1993, pp 139-157.
4. Asp N-G, Mattsson B, Önning G: Variation in dietary fibre, β-glucan, starch, protein, fat and hull content of oats grown in Sweden 1987-1989. Eur J Clin Nutr 1991;46:31-37.
5. Ripsin CM, Keenan JM, Jacobs DR, Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, Hegsted M, Davidson MH, Dugan LD, Demark-Wahnefriend W, Beling S: Oat products and lipid lowering: A meta-analysis. JAMA 1992;267:3317-3325.
6. Federal Register: Food Labelling: Health Claims; Oats and Coronary Heart Disease. 1996;61:296-337.
7. Rytter E, Erlanson-Albertsson C, Lindahl L, Lundquist I, Viherg U, Åkesson B, Öste R: Changes in plasma insulin, enterostatin and lipoproteins during an energy-restricted regimen including a new oat-based liquid food. Ann Nutr Metab 1996; 40:212-220.
8. Youngs VL: Oat lipids and lipidrelated enzymes; in Webster FH (ed): Oats: Chemistry and Technology. St. Paul, American Association of Cereal Chemists, 1986, pp 205-226.
9. Sirtori CR, Lovati MR, Manzoni C, Monetti M, Pazzucconi F, Gatti E: Soy and cholesterol reduction: Clinical experience. J Nutr 1995; 125(suppl):598-605.
10. Potter SM: Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125(suppl):606-611.
11. Artaud-Wild SM, Connor SL, Sexton G, Connor WE: Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: A paradox. Circulation 1993;88: 2771-2779.
12. McCleary BV, Codd R: Measurement of (1-3)(1-4)-β-glucan in barley and oats: A streamlined enzyme procedure. J Sci Food Agric 1991; 55:303-312.
13. Friedewald WT, Levy RJ, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Heding LA: A simplified insulin radioimmunoassay method; in Donato L, Milhaud G, Sirchis J (eds): Labelled Proteins in Tracer Studies. Brussels, Euratom, 1966, pp 345-350.
15. Federal Register: Food Labelling: Health Claims; Soluble Fiber from Whole Oats and Risk of Coronary Heart Disease. 1997;62: 15343-15344.
16. Behall KM, Scholfield DJ, Hallfrisch J: Effect of beta glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr 1997;16:46-51.
17. Van Horn L, Moag-Stahlberg A, Liu KA, Ballew C, Ruth K, Hughes R, Stamler J: Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 1991; 81:183-188.
18. Keenan JM, Wenz JB, Myers S, Ripsin CM, Huang Z: Randomized controlled crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract 1991;33:600-608.
19. Thompson LU, Jenkins DJA, Vic Amer MA, Reichert R, Jenkins A, Kamulsky J: The effect of fermented and unfermented milks on serum cholesterol. Am J Clin Nutr 1982; 36:1106-1111.
20. Rossouw JE, Burger E-M, Van der Vyver P, Ferreira JJ: The effect of skim milk, yoghurt, and full cream milk on human serum lipids. Am J Clin Nutr 1981;34:351-356.
21. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333:276-282.
22. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A: A novel method for measuring antioxidant capacity and its application to monitoring antioxidant status in premature neonates. Clin Sci 1993; 84:407-412.
23. Fernlund P, Hanson A, Laurell C-B, Lundh B: Klinisk kemi i praktisk medicin. Studentlitteratur, Lund 1986:534-536.
24. Turpeinen AM, Alfthan G, Valsta L, Hietanen E, Salonen JT, Schunk H, Nyyssönen K, Mutanen M: Plasma and lipoprotein lipid peroxidation in humans on sunflower and rapeseed oil diets. Lipids 1995;30:485-492.
25. Collins EW: Oat phenolics: Structure, occurrence, and function; in Webster FH (ed): Oats: Chemistry and Technology. St. Paul, American Association of Cereal Chemists, 1986, pp 227-295.
26. Dimberg LH, Theander O, Lingnert H: Avenanthramides - a group of phenolic antioxidants in oats. Cereal Chem 1993;70:637-641.
27. White PJ, Xing Y: Antioxidants from cereals and legumes: in Shahidi F (ed): Natural Antioxidants: Chemistry, Health Effects, and Applications. Champaign, AOCS Press, 1997, pp 25-63.
28. National Board of Health and Welfare, Sweden: Treatment of Hyperlipidemia. Information from the Medical Department, 1989, p 5.